Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Computational Biology (1)
- Advanced Manufacturing (3)
- Biological Systems (2)
- Biology and Environment (50)
- Clean Energy (36)
- Fusion and Fission (2)
- Materials (46)
- Materials for Computing (6)
- National Security (7)
- Neutron Science (102)
- Nuclear Science and Technology (9)
- Quantum information Science (1)
- Supercomputing (21)
News Type
Date
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.